Notably, SEMA3E was identified as a key prognostic gene using machine learning approaches, with its high expression levels linked to distinct immune subtypes and poor clinical outcomes in CRC, suggesting its potential as a diagnostic and prognostic biomarker (Zhu et al., 2025). Here, SEMA3E is linked to colorectal carcinoma.